Antileishmanial Anthracene Endoperoxides: Efficacy In Vitro, Mechanisms and Structure-Activity Relationships.
Leishmania
anthracene
electron paramagnetic resonance
endoperoxides
iron
radicals
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
13 Oct 2022
13 Oct 2022
Historique:
received:
09
09
2022
revised:
10
10
2022
accepted:
10
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
Leishmaniasis is a vector-borne disease caused by protozoal Leishmania parasites. Previous studies have shown that endoperoxides (EP) can selectively kill Leishmania in host cells. Therefore, we studied in this work a set of new anthracene-derived EP (AcEP) together with their non-endoperoxidic analogs in model systems of Leishmania tarentolae promastigotes (LtP) and J774 macrophages for their antileishmanial activity and selectivity. The mechanism of effective compounds was explored by studying their reaction with iron (II) in chemical systems and in Leishmania. The correlation of structural parameters with activity demonstrated that in this compound set, active compounds had a LogPOW larger than 3.5 and a polar surface area smaller than 100 Å2. The most effective compounds (IC50 in LtP < 2 µM) with the highest selectivity (SI > 30) were pyridyl-/tert-butyl-substituted AcEP. Interestingly, also their analogs demonstrated activity and selectivity. In mechanistic studies, it was shown that EP were activated by iron in chemical systems and in LtP due to their EP group. However, the molecular structure beyond the EP group significantly contributed to their differential mitochondrial inhibition in Leishmania. The identified compound pairs are a good starting point for subsequent experiments in pathogenic Leishmania in vitro and in animal models.
Identifiants
pubmed: 36296439
pii: molecules27206846
doi: 10.3390/molecules27206846
pmc: PMC9612231
pii:
doi:
Substances chimiques
Antiprotozoal Agents
0
anthracene
EH46A1TLD7
Anthracenes
0
Iron
E1UOL152H7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : FWF Austrian Science Fund
ID : P27814-B22
Références
J Med Microbiol. 2007 Sep;56(Pt 9):1213-1218
pubmed: 17761485
Molecules. 2016 Aug 10;21(8):
pubmed: 27517895
Eur J Med Chem. 2008 Feb;43(2):223-51
pubmed: 17618015
Free Radic Res. 2021 Mar;55(3):282-295
pubmed: 34121571
Redox Rep. 2003;8(5):284-8
pubmed: 14962366
Wkly Epidemiol Rec. ;92(38):557-65
pubmed: 28945057
Parasitol Res. 2013 Feb;112(2):825-8
pubmed: 23239091
Adv Drug Deliv Rev. 1999 Apr 5;36(2-3):229-254
pubmed: 10837718
Drug Discov Today. 2017 Oct;22(10):1516-1531
pubmed: 28647378
World Health Organ Tech Rep Ser. 2010;(949):xii-xiii, 1-186, back cover
pubmed: 21485694
PLoS Negl Trop Dis. 2016 Mar 03;10(3):e0004349
pubmed: 26937644
J Org Chem. 2017 Sep 1;82(17):9258-9262
pubmed: 28759234
F1000Res. 2017 May 26;6:750
pubmed: 28649370
Biochem Pharmacol. 2017 May 15;132:48-62
pubmed: 28263719
Int J Parasitol Drugs Drug Resist. 2019 Dec;11:106-117
pubmed: 31320296
Infect Genet Evol. 2017 Jun;50:121-127
pubmed: 27381333
Acta Trop. 2021 Sep;221:105988
pubmed: 34058160
Phytomedicine. 2014 Jul-Aug;21(8-9):1048-52
pubmed: 24768411
Molecules. 2021 Feb 04;26(4):
pubmed: 33557184
Nat Rev Drug Discov. 2015 Nov;14(11):751-8
pubmed: 26435527
Acc Chem Res. 2003 Sep;36(9):668-75
pubmed: 12974650
Exp Parasitol. 2009 Aug;122(4):299-305
pubmed: 19393240
Antimicrob Agents Chemother. 2009 Aug;53(8):3496-500
pubmed: 19487440
Parasitology. 2017 May;144(6):747-759
pubmed: 27938439
PLoS One. 2010 Jun 23;5(6):e11271
pubmed: 20585663
Chem Res Toxicol. 2010 Jan;23(1):193-202
pubmed: 20014750
J Biol Chem. 2004 Mar 19;279(12):11798-813
pubmed: 14679210
Curr Trop Med Rep. 2021;8(2):121-132
pubmed: 33747716
J Microbiol Methods. 2013 Aug;94(2):111-116
pubmed: 23707202
Parasitol Int. 2021 Feb;80:102218
pubmed: 33137506
J Magn Reson B. 1994 Jun;104(2):105-10
pubmed: 8049862
J Biol Chem. 1998 May 8;273(19):11401-4
pubmed: 9565547
Chem Commun (Camb). 2016 Jan 21;52(6):1210-3
pubmed: 26608846
Biochem Pharmacol. 2020 Mar;173:113737
pubmed: 31786259
Biochem Pharmacol. 2009 Feb 1;77(3):322-36
pubmed: 19022224
Antimicrob Agents Chemother. 2015 Aug;59(8):5032-5
pubmed: 26014947
Pharmacol Res. 2017 Mar;117:192-217
pubmed: 27867026
Molecules. 2018 Jul 10;23(7):
pubmed: 29996524
Antimicrob Agents Chemother. 2010 Mar;54(3):1042-6
pubmed: 20028825
Infect Immun. 2013 Oct;81(10):3620-6
pubmed: 23876801
Bioorg Med Chem. 2020 Apr 15;28(8):115432
pubmed: 32192852
Curr Opin Microbiol. 2013 Dec;16(6):716-21
pubmed: 23962817
Nat Rev Microbiol. 2011 Jul 11;9(8):604-15
pubmed: 21747391
Exp Parasitol. 2010 Dec;126(4):471-5
pubmed: 20685203
Free Radic Res. 2011 Apr;45(4):417-30
pubmed: 21128732
Free Radic Res. 2001 Oct;35(4):427-34
pubmed: 11697139
Langmuir. 2010 Mar 16;26(6):4421-8
pubmed: 20052984
Parasitol Res. 1990;76(7):570-2
pubmed: 2217117
J Med Chem. 2013 Dec 27;56(24):10171-82
pubmed: 24299550
NeuroRx. 2005 Oct;2(4):541-53
pubmed: 16489364
Drug Des Devel Ther. 2016 Nov 01;10:3575-3590
pubmed: 27843298
Antimicrob Agents Chemother. 2007 Aug;51(8):2991-3
pubmed: 17562801
PLoS Negl Trop Dis. 2019 Dec 2;13(12):e0007885
pubmed: 31790397
Chemistry. 2006 Dec 13;12(36):9276-83
pubmed: 17004286
J Am Chem Soc. 2004 Feb 18;126(6):1688-98
pubmed: 14871099
Phytomedicine. 2011 Sep 15;18(12):1056-69
pubmed: 21596544
Angew Chem Int Ed Engl. 2018 Sep 24;57(39):12971-12975
pubmed: 30070421